Loading...

Yasuhiro Kodera

Title(s)Assistant Researcher, Mechanical and Aerospace Engineering
SchoolVc-academic Affairs
Address9500 Gilman Drive #0411
La Jolla CA 92093
Phone000-000-NULL
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells. Cancer Sci. 2020 Sep 02. Chen C, Enomoto A, Weng L, Taki T, Shiraki Y, Mii S, Ichihara R, Kanda M, Koike M, Kodera Y, Takahashi M. PMID: 32875699.
      View in: PubMed   Mentions:    Fields:    
    2. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2020 Sep 01. Suenaga M, Fujii T, Yamada S, Hayashi M, Shinjo K, Takami H, Niwa Y, Sonohara F, Shimizu D, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kondo Y, Kodera Y. PMID: 32875467.
      View in: PubMed   Mentions:    Fields:    
    3. STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer. Cancer Genomics Proteomics. 2020 Sep-Oct; 17(5):509-516. Nakamura S, Kanda M, Shimizu D, Sawaki K, Tanaka C, Hattori N, Hayashi M, Yamada S, Nakayama G, Omae K, Koike M, Kodera Y. PMID: 32859629.
      View in: PubMed   Mentions:    Fields:    
    4. Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer. Mol Cancer. 2020 Aug 26; 19(1):131. Kanda M, Shimizu D, Sawaki K, Nakamura S, Umeda S, Miwa T, Tanaka H, Tanaka C, Hayashi M, Iguchi Y, Yamada S, Katsuno M, Kodera Y. PMID: 32847597.
      View in: PubMed   Mentions:    Fields:    
    5. Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by incurable advanced gastric cancer. Gastric Cancer. 2020 Aug 13. Terashima M, Fujitani K, Ando M, Sakamaki K, Kawabata R, Ito Y, Yoshikawa T, Kondo M, Kodera Y, Kaji M, Oka Y, Imamura H, Kawada J, Takagane A, Shimada H, Tanizawa Y, Yamanaka T, Morita S, Ninomiya M, Yoshida K. PMID: 32789710.
      View in: PubMed   Mentions:    Fields:    
    6. Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institution. Jpn J Clin Oncol. 2020 Jul 23. Ishii K, Yokoyama Y, Nishida Y, Koike H, Yamada S, Kodera Y, Sassa N, Gotoh M, Nagino M. PMID: 32699905.
      View in: PubMed   Mentions:    Fields:    
    7. What is the impact of systemic chemotherapy for lateral lymph nodes in patients with locally advanced low rectal cancer? Int J Colorectal Dis. 2020 Jul 16. Ogura A, Uehara K, Aiba T, Hattori N, Nakayama G, Maeda O, Ando Y, Kodera Y, Ebata T, Nagino M. PMID: 32676686.
      View in: PubMed   Mentions:    Fields:    
    8. Newly developed primary malignancies in long-term survivors who underwent curative esophagectomy for squamous cell carcinoma of the esophagus. Surg Today. 2020 Jul 07. Shimizu D, Koike M, Kanda M, Sonohara F, Hattori N, Hayashi M, Tanaka C, Yamada S, Kodera Y. PMID: 32638131.
      View in: PubMed   Mentions:    Fields:    
    9. [Current Status and Future Perspectives of the Treatment of Rare Cancer-The Treatment Guidelines for Duodenal Cancer]. Gan To Kagaku Ryoho. 2020 Jul; 47(7):1012-1015. Kodera Y. PMID: 32668841.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Chromobox 2 Expression Predicts Prognosis After Curative Resection of Oesophageal Squamous Cell Carcinoma. Cancer Genomics Proteomics. 2020 Jul-Aug; 17(4):391-400. Ueda S, Kanda M, Sato Y, Baba H, Nakamura S, Sawaki K, Shimizu D, Motoyama S, Fujii T, Kodera Y, Nomoto S. PMID: 32576584.
      View in: PubMed   Mentions:    Fields:    
    11. Phase II multi-institutional prospective trial of nab-paclitaxel as second-line chemotherapy for advanced gastric cancer refractory to fluoropyrimidine with modified dose reduction criteria (CCOG1303). Int J Clin Oncol. 2020 Jun 21. Kobayashi D, Mochizuki Y, Torii K, Takeda S, Kawase Y, Ishigure K, Teramoto H, Ando M, Kodera Y. PMID: 32567012.
      View in: PubMed   Mentions:    Fields:    
    12. An Open-Label Single-Arm Phase II Study of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus. Oncologist. 2020 Jun 18. Kanda M, Koike M, Iwata N, Shimizu D, Tanaka C, Hattori N, Hayashi M, Yamada S, Omae K, Nakayama G, Kodera Y. PMID: 32557987.
      View in: PubMed   Mentions:    Fields:    
    13. High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma Recurrences. Nutr Cancer. 2020 Jun 15; 1-8. Hayashi M, Yamada S, Tanabe H, Takami H, Inokawa Y, Sonohara F, Shimizu D, Hattori N, Kanda M, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 32538144.
      View in: PubMed   Mentions:    Fields:    
    14. Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer. Cancer Med. 2020 Aug; 9(15):5392-5399. Sawaki K, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 32515147.
      View in: PubMed   Mentions: 1     Fields:    
    15. Comparison of Postoperative Quality of Life among Three Different Reconstruction Methods After Proximal Gastrectomy: Insights From the PGSAS Study. World J Surg. 2020 Jun 06. Yabusaki H, Kodera Y, Fukushima N, Hiki N, Kinami S, Yoshida M, Aoyagi K, Ota S, Hata H, Noro H, Oshio A, Nakada K. PMID: 32506229.
      View in: PubMed   Mentions:    Fields:    
    16. Is there disparity between regions and facilities in surgical resident training in Japan? Insights from a national survey. Surg Today. 2020 Jun 02. Hashimoto D, Poudel S, Hirano S, Kurashima Y, Akiyama H, Eguchi S, Fukui T, Hagiwara M, Hida K, Izaki T, Iwase H, Kawamoto S, Otomo Y, Nagai E, Saito M, Takami H, Takeda Y, Toi M, Yamaue H, Yoshida M, Yoshida S, Ohki T, Kodera Y. PMID: 32488479.
      View in: PubMed   Mentions:    Fields:    
    17. Pelvic exenteration associated with future renal dysfunction. Surg Today. 2020 Jun 01. Sando M, Uehara K, Li Y, Aiba T, Ogura A, Ebata T, Kodera Y, Yatsuya H, Nagino M. PMID: 32488476.
      View in: PubMed   Mentions:    Fields:    
    18. Impact of Qualitative and Quantitative Biliary Contamination Status on the Incidence of Postoperative Infection Complications in Patients Undergoing Pancreatoduodenectomy. Ann Surg Oncol. 2020 May 28. Suenaga M, Yokoyama Y, Fujii T, Yamada S, Yamaguchi J, Hayashi M, Asahara T, Nagino M, Kodera Y. PMID: 32468346.
      View in: PubMed   Mentions:    Fields:    
    19. D2 lymph node dissection confers little benefit on the overall survival of older patients with resectable gastric cancer: a propensity score-matching analysis of a multi-institutional dataset. Surg Today. 2020 May 25. Shinozuka T, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 32451713.
      View in: PubMed   Mentions:    Fields:    
    20. Preoperative risk factors for postoperative intra-abdominal infectious complication after gastrectomy for gastric cancer using a Japanese web-based nationwide database. Gastric Cancer. 2020 May 21. Fujiya K, Kumamaru H, Fujiwara Y, Miyata H, Tsuburaya A, Kodera Y, Kitagawa Y, Konno H, Terashima M. PMID: 32440807.
      View in: PubMed   Mentions:    Fields:    
    21. Pancreatic Fat and Body Composition Measurements by Computed Tomography are Associated with Pancreatic Fistula After Pancreatectomy. Ann Surg Oncol. 2020 May 20. Tanaka K, Yamada S, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 32436185.
      View in: PubMed   Mentions:    Fields:    
    22. Tumor marker recovery rather than major pathological response is a preferable prognostic factor in patients with pancreatic ductal adenocarcinoma with preoperative therapy. J Hepatobiliary Pancreat Sci. 2020 Aug; 27(8):487-495. Yamada S, Yokoyama Y, Sonohara F, Yamaguchi J, Takami H, Hayashi M, Onoe S, Fujii T, Nagino M, Kodera Y. PMID: 32359199.
      View in: PubMed   Mentions:    Fields:    
    23. ASO Authors Reflections: Preoperative Pancreatic Fat and Body Composition Measurements Influence the Incidence of Grade B/C Postoperative Pancreatic Fistula After Pancreatectomy. Ann Surg Oncol. 2020 May 14. Tanaka K, Yamada S, Hayashi M, Kodera Y. PMID: 32409972.
      View in: PubMed   Mentions:    Fields:    
    24. Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma. Ann Surg. 2020 May 08. Kandimalla R, Shimura T, Mallik S, Sonohara F, Tsai S, Evans DB, Kim SC, Baba H, Kodera Y, Von Hoff D, Chen X, Goel A. PMID: 32398486.
      View in: PubMed   Mentions:    Fields:    
    25. Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer. Pancreas. 2020 May/Jun; 49(5):699-705. Morimoto D, Yamada S, Sonohara F, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. PMID: 32433409.
      View in: PubMed   Mentions:    Fields:    
    26. Systemic Inflammation Score as a Predictor of Pneumonia after Radical Resection of Gastric Cancer: Analysis of a Multi-Institutional Dataset. Dig Surg. 2020 Apr 28; 1-10. Shoka M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 32344400.
      View in: PubMed   Mentions:    Fields:    
    27. An outcome analysis of predictive factors for portal or splenic vein thrombosis after distal pancreatectomy. Surg Today. 2020 Apr 28. Tanaka N, Yamada S, Sonohara F, Takami H, Hayashi M, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. PMID: 32346760.
      View in: PubMed   Mentions:    Fields:    
    28. Is the measurement of drain amylase content useful for predicting pancreas-related complications after gastrectomy with systematic lymphadenectomy? World J Gastroenterol. 2020 Apr 14; 26(14):1594-1600. Nakanishi K, Kanda M, Sakamoto J, Kodera Y. PMID: 32327908.
      View in: PubMed   Mentions:    Fields:    
    29. ASO Author Reflections: Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2020 Sep; 27(9):3257-3258. Baba H, Kanda M, Kodera Y, Fujii T. PMID: 32277319.
      View in: PubMed   Mentions:    Fields:    
    30. Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2020 Sep; 27(9):3247-3256. Baba H, Kanda M, Sato Y, Sawaki K, Shimizu D, Koike M, Motoyama S, Kodera Y, Fujii T. PMID: 32253672.
      View in: PubMed   Mentions:    Fields:    
    31. Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus. Ann Surg Oncol. 2020 Sep; 27(9):3195-3205. Kanda M, Koike M, Shimizu D, Tanaka C, Hattori N, Hayashi M, Yamada S, Omae K, Kodera Y. PMID: 32246314.
      View in: PubMed   Mentions:    Fields:    
    32. ASO Author Reflections: Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus. Ann Surg Oncol. 2020 Sep; 27(9):3206-3207. Kanda M, Koike M, Kodera Y. PMID: 32246315.
      View in: PubMed   Mentions:    Fields:    
    33. Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer. Anticancer Res. 2020 Apr; 40(4):1843-1853. Sonohara F, Yamada S, Takeda S, Hayashi M, Suenaga M, Sunagawa Y, Tashiro M, Takami H, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 32234872.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    34. ASO Author Reflections: KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2020 Jul; 27(7):2569-2570. Nakamura S, Kanda M, Kodera Y. PMID: 32166595.
      View in: PubMed   Mentions:    Fields:    
    35. Preoperative six-minute walk distance as a predictor of postoperative complication in patients with esophageal cancer. Dis Esophagus. 2020 Mar 05; 33(2). Inoue T, Ito S, Kanda M, Niwa Y, Nagaya M, Nishida Y, Hasegawa Y, Koike M, Kodera Y. PMID: 31111872.
      View in: PubMed   Mentions: 2     Fields:    
    36. Are graduating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in Japan. Surg Today. 2020 Sep; 50(9):995-1001. Poudel S, Hirano S, Kurashima Y, Stefanidis D, Akiyama H, Eguchi S, Fukui T, Hagiwara M, Hashimoto D, Hida K, Izaki T, Iwase H, Kawamoto S, Otomo Y, Nagai E, Saito M, Takami H, Takeda Y, Toi M, Yamaue H, Yoshida M, Yoshida S, Kodera Y. PMID: 32125504.
      View in: PubMed   Mentions:    Fields:    
    37. Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies. J Gastroenterol. 2020 Jun; 55(6):653-661. Mizuno K, Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Kawashima H, Inukai Y, Toyoda H, Yokota K, Hase T, Maeda O, Kiyoi H, Nagino M, Hibi H, Kodera Y, Fujimoto Y, Sone M, Gotoh M, Ando Y, Akiyama M, Hasegawa Y, Fujishiro M. PMID: 32124082.
      View in: PubMed   Mentions:    Fields:    
    38. Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models. Anticancer Drugs. 2020 03; 31(3):241-250. Shu S, Yamashita-Kashima Y, Yanagisawa M, Nakanishi H, Kodera Y, Harada N, Yoshimura Y. PMID: 31633500.
      View in: PubMed   Mentions:    Fields:    
    39. Propensity-score-matched analysis of a multi-institutional dataset to compare postoperative complications between Billroth I and Roux-en-Y reconstructions after distal gastrectomy. Gastric Cancer. 2020 Jul; 23(4):734-745. Nakanishi K, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Shimizu D, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 32065304.
      View in: PubMed   Mentions: 1     Fields:    
    40. KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2020 Jul; 27(7):2559-2568. Nakamura S, Kanda M, Koike M, Shimizu D, Umeda S, Hattori N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Omae K, Kodera Y. PMID: 32052303.
      View in: PubMed   Mentions: 1     Fields:    
    41. Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study. Br J Cancer. 2020 Mar; 122(6):771-777. Okada N, Iwama S, Okuji T, Kobayashi T, Yasuda Y, Wada E, Onoue T, Goto M, Sugiyama M, Tsunekawa T, Takagi H, Hagiwara D, Ito Y, Suga H, Banno R, Hase T, Morise M, Kanda M, Yokota K, Hashimoto N, Ando M, Fujimoto Y, Nagino M, Kodera Y, Fujishiro M, Hibi H, Sone M, Kiyoi H, Gotoh M, Ando Y, Akiyama M, Hasegawa Y, Arima H. PMID: 32009131.
      View in: PubMed   Mentions: 2     Fields:    
    42. A prospective trial to evaluate treatment effects of a ß-hydroxy-ß-methylbutyrate containing nutrient for leakage at the anastomotic site after esophagectomy. Nagoya J Med Sci. 2020 Feb; 82(1):33-37. Kanda M, Koike M, Fukaya M, Miyata K, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Murotani K, Fujiwara M, Nagino M, Kodera Y. PMID: 32273630.
      View in: PubMed   Mentions:    Fields:    
    43. Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancer. Surg Today. 2020 Aug; 50(8):912-919. Mukai T, Uehara K, Aiba T, Ogura A, Tsuzuki T, Tanaka A, Sando M, Ohara N, Sato Y, Hattori N, Nakayama G, Kodera Y, Nagino M. PMID: 31989238.
      View in: PubMed   Mentions:    Fields:    
    44. Treatment option of endoscopic stent insertion or gastrojejunostomy for gastric outlet obstruction due to gastric cancer: a propensity score-matched analysis. Gastric Cancer. 2020 Jul; 23(4):667-676. Haga Y, Hiki N, Kinoshita T, Ojima T, Nabeya Y, Kuwabara S, Seto Y, Yajima K, Takeuchi H, Yoshida K, Kodera Y, Fujiwara Y, Baba H. PMID: 31982964.
      View in: PubMed   Mentions: 2     Fields:    
    45. Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology. Int J Clin Oncol. 2020 Mar; 25(3):403-417. Naito Y, Mishima S, Akagi K, Igarashi A, Ikeda M, Okano S, Kato S, Takano T, Tsuchihara K, Terashima K, Nishihara H, Nishiyama H, Hiyama E, Hirasawa A, Hosoi H, Maeda O, Yatabe Y, Okamoto W, Ono S, Kajiyama H, Nagashima F, Hatanaka Y, Miyachi M, Kodera Y, Yoshino T, Taniguchi H. PMID: 31974683.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2-3N0 Gastric Cancer: a Multi-institutional Dataset Analysis. J Gastric Cancer. 2020 Mar; 20(1):41-49. Fujita K, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 32269843.
      View in: PubMed   Mentions:
    47. Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments. Int J Clin Oncol. 2020 May; 25(5):929-936. Sassa N, Yokoyama Y, Nishida Y, Yamada S, Uchida H, Kajiyama H, Nagino M, Kodera Y, Gotoh M. PMID: 31950376.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness. Anticancer Res. 2020 Jan; 40(1):201-211. Hirabayashi S, Hayashi M, Nakayama G, Mii S, Hattori N, Tanabe H, Kanda M, Tanaka C, Kobayashi D, Yamada S, Koike M, Fujiwara M, Takahashi M, Kodera Y. PMID: 31892568.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    49. Tumor size ?=50 mm as an Independent Prognostic Factor for Patients with Stage II or III Gastric Cancer After Postoperative S-1 Monotherapy: Analysis of a Multi-institution Dataset. World J Surg. 2020 01; 44(1):194-201. Tsutsuyama M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 31552460.
      View in: PubMed   Mentions:    Fields:    
    50. A message from the new editor-in-chief. Gastric Cancer. 2020 01; 23(1):1-2. Kodera Y. PMID: 31673843.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer. Ann Surg Oncol. 2020 Mar; 27(3):887-895. Nakagawa N, Yamada S, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 31848811.
      View in: PubMed   Mentions: 1     Fields:    
    52. ASO Author Reflections: The Naples Prognostic Score Predicts Long-Term Survival in Patients with Resected Pancreatic Cancer. Ann Surg Oncol. 2020 Mar; 27(3):896-897. Nakagawa N, Yamada S, Kodera Y. PMID: 31848821.
      View in: PubMed   Mentions:    Fields:    
    53. Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines. In Vivo. 2019 Nov-Dec; 33(6):1785-1792. Miwa T, Kanda M, Umeda S, Tanaka H, Shimizu D, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. PMID: 31662503.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    54. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer. Anticancer Res. 2019 Nov; 39(11):5903-5910. Endo M, Kanda M, Sawaki K, Shimizu D, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Yamada S, Koike M, Omae K, Kodera Y. PMID: 31704814.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    55. PRAME Expression as a Potential Biomarker for Hematogenous Recurrence of Esophageal Squamous Cell Carcinoma. Anticancer Res. 2019 Nov; 39(11):5943-5951. Baba H, Kanda M, Sawaki K, Shimizu D, Umeda S, Koike M, Kodera Y, Fujii T. PMID: 31704819.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma. Anticancer Res. 2019 Nov; 39(11):6015-6023. Uno Y, Kanda M, Sato Y, Shimizu D, Umeda S, Hattori N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Nakayama G, Motoyama S, Koike M, Kodera Y. PMID: 31704827.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    57. Level of Melanotransferrin in Tissue and Sera Serves as a Prognostic Marker of Gastric Cancer. Anticancer Res. 2019 Nov; 39(11):6125-6133. Sawaki K, Kanda M, Umeda S, Miwa T, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Omae K, Koike M, Kodera Y. PMID: 31704840.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    58. Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. Ann Surg Oncol. 2020 Jun; 27(6):2081-2089. Sunagawa Y, Yamada S, Sato Y, Morimoto D, Sonohara F, Takami H, Inokawa Y, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. PMID: 31673938.
      View in: PubMed   Mentions:    Fields:    
    59. Genomewide Expression Profiling Identifies a Novel miRNA-Based Signature for the Detection of Peritoneal Metastasis in Patients With Gastric Cancer. Ann Surg. 2019 Oct 28. Shimura T, Toden S, Kandimalla R, Toiyama Y, Okugawa Y, Kanda M, Baba H, Kodera Y, Kusunoki M, Goel A. PMID: 31663973.
      View in: PubMed   Mentions: 1     Fields:    
    60. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer. Ann Surg Oncol. 2020 Jun; 27(6):2071-2080. Baba H, Kanda M, Sawaki K, Umeda S, Miwa T, Shimizu D, Tanaka C, Kobayashi D, Fujiwara M, Kodera Y, Fujii T. PMID: 31659640.
      View in: PubMed   Mentions:    Fields:    
    61. Clinical impact of additional therapy for residual pancreatic cancer. Surg Today. 2020 May; 50(5):440-448. Yamada S, Sonohara F, Tashiro M, Murotani K, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujii T, Kodera Y. PMID: 31650262.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus. Ann Surg Oncol. 2020 Apr; 27(4):1233-1240. Kanda M, Koike M, Shimizu D, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Omae K, Yamada S, Nakayama G, Kodera Y. PMID: 31650302.
      View in: PubMed   Mentions:    Fields:    
    63. Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer. Int J Cancer. 2020 May 15; 146(10):2865-2876. Umeda S, Kanda M, Miwa T, Tanaka H, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. PMID: 31597194.
      View in: PubMed   Mentions: 1     Fields:    
    64. Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis. BMC Surg. 2019 Oct 15; 19(1):143. Kanda M, Koike M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Omae K, Kodera Y. PMID: 31615499.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus. Ann Surg Oncol. 2019 Dec; 26(13):4773-4781. Kanda M, Koike M, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Yamada S, Omae K, Fujiwara M, Kodera Y. PMID: 31605344.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II). Int J Clin Oncol. 2020 Jan; 25(1):118-125. Hattori N, Nakayama G, Uehara K, Aiba T, Ishigure K, Sakamoto E, Tojima Y, Kanda M, Kobayashi D, Tanaka C, Yamada S, Koike M, Fujiwara M, Nagino M, Kodera Y. PMID: 31542847.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    67. Prognosis After Laparoscopic Gastrectomy in Patients with Pathological Stage II or III Gastric Cancer Who Were Preoperatively Diagnosed with Clinical Stage I: Propensity Score Matching Analysis of a Multicenter Dataset. Ann Surg Oncol. 2020 Jan; 27(1):268-275. Ito Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 31493125.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis. Oncology. 2020; 98(1):48-52. Kobayashi D, Ishigami H, Kanda M, Tanaka C, Yamaguchi H, Kitayama J, Kodera Y. PMID: 31487733.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    69. Dynamics of Circulating Tumor Cells Early After Targeting Therapy to Human EGFR-mutated Lung Cancers and HER2 Gene-amplified Gastric Cancers in Mice. Anticancer Res. 2019 Sep; 39(9):4711-4720. Ito A, Nakanishi H, Yoshimura M, Ito S, Sakao Y, Kodera Y, Yatabe Y, Kaneda N. PMID: 31519570.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    70. Incorporating molecular biomarkers into clinical practice for gastric cancer. Expert Rev Anticancer Ther. 2019 09; 19(9):757-771. Nakamura S, Kanda M, Kodera Y. PMID: 31437076.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study. Gastric Cancer. 2020 03; 23(2):203-211. Kanda M, Suh YS, Park DJ, Tanaka C, Ahn SH, Kong SH, Lee HJ, Kobayashi D, Fujiwara M, Shimada H, Cho B, Murotani K, Kim HH, Yang HK, Kodera Y. PMID: 31377880.
      View in: PubMed   Mentions: 4     Fields:    
    72. Proposal of a Scoring Scale to Estimate Risk of the Discontinuation of S-1 Adjuvant Monotherapy in Patients with Stage II to III Gastric Cancer: A Multi-Institutional Dataset Analysis. World J Surg. 2019 08; 43(8):2016-2024. Iizuka A, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 30737551.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer. Cancer Med. 2019 Sep; 8(11):5194-5201. Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 31353821.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Clin Cancer Res. 2019 10 15; 25(20):6170-6179. Yamamura K, Izumi D, Kandimalla R, Sonohara F, Baba Y, Yoshida N, Kodera Y, Baba H, Goel A. PMID: 31358543.
      View in: PubMed   Mentions: 4     Fields:    
    75. Comparison of non-invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma. Hepatol Res. 2019 Nov; 49(11):1305-1315. Sonohara F, Yamada S, Tanaka N, Tashiro M, Sunagawa Y, Morimoto D, Tanaka H, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 31260575.
      View in: PubMed   Mentions:
    76. Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition. Int J Clin Oncol. 2020 Feb; 25(2):217-239. Mishima S, Taniguchi H, Akagi K, Baba E, Fujiwara Y, Hirasawa A, Ikeda M, Maeda O, Muro K, Nishihara H, Nishiyama H, Takano T, Tsuchihara K, Yatabe Y, Kodera Y, Yoshino T. PMID: 31286289.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    77. Recent advances in molecular biomarkers for patients with hepatocellular carcinoma. Expert Rev Mol Diagn. 2019 08; 19(8):725-738. Umeda S, Kanda M, Kodera Y. PMID: 31248309.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    78. Splenectomy in living donor liver transplantation and risk factors of portal vein thrombosis. Hepatobiliary Pancreat Dis Int. 2019 Aug; 18(4):337-342. Kurata N, Ogura Y, Ogiso S, Onishi Y, Kamei H, Kodera Y. PMID: 31278029.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Long-lasting discussion: Adverse effects of intraoperative blood loss and allogeneic transfusion on prognosis of patients with gastric cancer. World J Gastroenterol. 2019 Jun 14; 25(22):2743-2751. Nakanishi K, Kanda M, Kodera Y. PMID: 31235997.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    80. Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase Concentrations. Ann Surg Oncol. 2019 Oct; 26(11):3718-3726. Kanda M, Koike M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Omae K, Kodera Y. PMID: 31197518.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    81. Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens. Eur J Surg Oncol. 2019 Oct; 45(10):1895-1900. Sonohara F, Yamada S, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. PMID: 31147087.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey. Surg Today. 2019 Oct; 49(10):870-876. Poudel S, Hirano S, Kurashima Y, Stefanidis D, Akiyama H, Eguchi S, Fukui T, Hagiwara M, Hashimoto D, Hida K, Izaki T, Iwase H, Kawamoto S, Otomo Y, Nagai E, Saito M, Takami H, Takeda Y, Toi M, Yamaue H, Yoshida M, Yoshida S, Kodera Y. PMID: 31102022.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    83. Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth. Mol Ther Oncolytics. 2019 Jun 28; 13:107-115. Wu Z, Ichinose T, Naoe Y, Matsumura S, Villalobos IB, Eissa IR, Yamada S, Miyajima N, Morimoto D, Mukoyama N, Nishikawa Y, Koide Y, Kodera Y, Tanaka M, Kasuya H. PMID: 31193737.
      View in: PubMed   Mentions:
    84. Detection of indocyanine green fluorescence to determine tumor location during laparoscopic gastrectomy for gastric cancer: Results of a prospective study. Asian J Endosc Surg. 2020 Apr; 13(2):160-167. Tanaka C, Kanda M, Funasaka K, Miyahara R, Murotani K, Tanaka Y, Takeda S, Kobayashi D, Hirooka Y, Fujiwara M, Goto H, Kodera Y. PMID: 31070004.
      View in: PubMed   Mentions:    Fields:    
    85. The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer. Gastric Cancer. 2019 11; 22(6):1143-1152. Nakanishi K, Kanda M, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Kodera Y. PMID: 31055693.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    86. Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study. Nagoya J Med Sci. 2019 May; 81(2):233-239. Takano N, Yamada S, Hirakawa A, Yokoyama Y, Kawashima H, Maeda O, Okada T, Ohno E, Yamaguchi J, Ishikawa T, Sonohara F, Suenaga M, Takami H, Hayashi M, Niwa Y, Hirooka Y, Ito Y, Naganawa S, Ando Y, Nagino M, Goto H, Fujii T, Kodera Y. PMID: 31239592.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    87. Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma. Ann Surg. 2019 05; 269(5):879-886. Sonohara F, Gao F, Iwata N, Kanda M, Koike M, Takahashi N, Yamada Y, Kodera Y, Wang X, Goel A. PMID: 29240008.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    88. Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy. J Gastric Cancer. 2019 Jun; 19(2):183-192. Miwa T, Kanda M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. PMID: 31245163.
      View in: PubMed   Mentions:
    89. Effects of duration of initial treatment on postoperative complications in pancreatic cancer. J Hepatobiliary Pancreat Sci. 2019 Jun; 26(6):235-241. Yamada S, Takami H, Sonohara F, Hayashi M, Fujii T, Kodera Y. PMID: 30919565.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    90. Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset. Gastric Cancer. 2019 11; 22(6):1215-1225. Nakanishi K, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 30955110.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    91. Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial. J Clin Oncol. 2019 05 20; 37(15):1296-1304. Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. PMID: 30925125.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    92. The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset. Dig Surg. 2020; 37(2):135-144. Sasahara M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 30840952.
      View in: PubMed   Mentions:    Fields:    
    93. Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional Dataset. World J Surg. 2019 Mar; 43(3):870-877. Ito Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 30377722.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    94. Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform. PLoS One. 2019; 14(2):e0212221. Tsutsuyama M, Nakanishi H, Yoshimura M, Oshiro T, Kinoshita T, Komori K, Shimizu Y, Ichinosawa Y, Kinuta S, Wajima K, Sakakibara Y, Yatabe Y, Ito S, Kodera Y. PMID: 30811434.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    95. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer. HPB (Oxford). 2019 09; 21(9):1211-1218. Kato Y, Yamada S, Tashiro M, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 30773450.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    96. A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer. EBioMedicine. 2019 Mar; 41:268-275. Izumi D, Gao F, Toden S, Sonohara F, Kanda M, Ishimoto T, Kodera Y, Wang X, Baba H, Goel A. PMID: 30772302.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    97. Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival. Ann Surg Oncol. 2019 May; 26(5):1535-1543. Miwa T, Kanda M, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. PMID: 30673899.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    98. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer. World J Gastrointest Oncol. 2019 Jan 15; 11(1):17-27. Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 30984347.
      View in: PubMed   Mentions:
    99. Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer. Ann Surg Oncol. 2019 Mar; 26(3):836-844. Uno Y, Kanda M, Miwa T, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. PMID: 30617870.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    100. Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy. J Transl Med. 2019 01 03; 17(1):1. Niwa Y, Yamada S, Sonohara F, Kurimoto K, Hayashi M, Tashiro M, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 30602370.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    101. CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis. Anticancer Res. 2019 Jan; 39(1):99-106. Shimizu D, Masuda T, Sato K, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Kodera Y, Mimori K. PMID: 30591445.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    102. Background factors influencing postgastrectomy syndromes after various types of gastrectomy. World J Clin Cases. 2018 Dec 26; 6(16):1111-1120. Kinami S, Takahashi M, Urushihara T, Ikeda M, Yoshida M, Uenosono Y, Oshio A, Suzukamo Y, Terashima M, Kodera Y, Nakada K. PMID: 30613669.
      View in: PubMed   Mentions:
    103. The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set. Ann Surg Oncol. 2019 Feb; 26(2):456-464. Ryo S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 30565044.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    104. Surgical risk and benefits of laparoscopic surgery for elderly patients with gastric cancer: a multicenter prospective cohort study. Gastric Cancer. 2019 07; 22(4):845-852. Honda M, Kumamaru H, Etoh T, Miyata H, Yamashita Y, Yoshida K, Kodera Y, Kakeji Y, Inomata M, Konno H, Seto Y, Kitano S, Watanabe M, Hiki N. PMID: 30539321.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    105. Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Gastric Cancer. 2019 07; 22(4):853-863. Hayashi S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 30483985.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    106. Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi-institutional dataset. Cancer Med. 2018 12; 7(12):6020-6029. Nakagawa N, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. PMID: 30411544.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    107. Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification. Pancreas. 2018 Nov/Dec; 47(10):1350-1356. Morimoto D, Yamada S, Murotani K, Sonohara F, Takami H, Suenaga M, Hayashi M, Niwa Y, Tashiro M, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. PMID: 30286011.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    108. Long-term quality of life and nutrition status of the aboral pouch reconstruction after total gastrectomy for gastric cancer: a prospective multicenter observational study (CCOG1505). Gastric Cancer. 2019 05; 22(3):607-616. Tanaka C, Kanda M, Murotani K, Yoshikawa T, Cho H, Ito Y, Matsui T, Nakayama H, Yamada T, Kobayashi D, Fujiwara M, Kodera Y. PMID: 30382468.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    109. A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma. Int J Cancer. 2019 03 01; 144(5):1160-1169. Roy R, Kandimalla R, Sonohara F, Koike M, Kodera Y, Takahashi N, Yamada Y, Goel A. PMID: 30006931.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    110. Cutting-edge evidence of adjuvant treatments for gastric cancer. Expert Rev Gastroenterol Hepatol. 2018 Nov; 12(11):1109-1122. Shimizu D, Kanda M, Kodera Y, Sakamoto J. PMID: 30274536.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    111. RASEF expression correlates with hormone receptor status in breast cancer. Oncol Lett. 2018 Dec; 16(6):7223-7230. Shibata M, Kanda M, Shimizu D, Tanaka H, Umeda S, Miwa T, Hayashi M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Kodera Y, Kikumori T. PMID: 30546460.
      View in: PubMed   Mentions:
    112. Significance of Preoperative Systemic Inflammation Score in Short-Term and Long-Term Outcomes of Patients with Pathological T2-4 Gastric Cancer After Radical Gastrectomy. World J Surg. 2018 10; 42(10):3277-3285. Sato B, Kanda M, Tanaka C, Kobayashi D, Iwata N, Hattori N, Suenaga M, Hayashi M, Yamada S, Murotani K, Fujiwara M, Kodera Y. PMID: 29560531.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    113. Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma. Oncol Rep. 2018 Dec; 40(6):3772-3780. Umeda S, Kanda M, Koike M, Tanaka H, Miwa T, Tanaka C, Kobayashi D, Suenaga M, Hayashi M, Yamada S, Nakayama G, Kodera Y. PMID: 30272363.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    114. Expression of sushi domain containing two reflects the malignant potential of gastric cancer. Cancer Med. 2018 10; 7(10):5194-5204. Umeda S, Kanda M, Miwa T, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. PMID: 30259711.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    115. Perioperative and prognostic implication of albumin-bilirubin-TNM score in Child-Pugh class A hepatocellular carcinoma. Ann Gastroenterol Surg. 2019 Jan; 3(1):65-74. Sonohara F, Yamada S, Tanaka N, Suenaga M, Takami H, Hayashi M, Niwa Y, Sugimoto H, Hattori N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 30697612.
      View in: PubMed   Mentions:
    116. The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers. Cancers (Basel). 2018 Sep 26; 10(10). Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. PMID: 30261620.
      View in: PubMed   Mentions:
    117. Dual-center randomized clinical trial exploring the optimal duration of antimicrobial prophylaxis in patients undergoing pancreaticoduodenectomy following biliary drainage. Ann Gastroenterol Surg. 2018 Nov; 2(6):442-450. Yamamoto T, Satoi S, Fujii T, Yamada S, Yanagimoto H, Yamaki S, Takami H, Hirooka S, Kosaka H, Kotsuka M, Miyara T, Kodera Y. PMID: 30460348.
      View in: PubMed   Mentions:
    118. Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD. Oncol Lett. 2018 Nov; 16(5):6847-6853. Maeda H, Okada KI, Fujii T, Oba MS, Kawai M, Hirono S, Kodera Y, Sho M, Akahori T, Shimizu Y, Ambo Y, Kondo N, Murakami Y, Ohuchida J, Eguchi H, Nagano H, Sakamoto J, Yamaue H. PMID: 30333892.
      View in: PubMed   Mentions:
    119. Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms. Pancreas. 2018 09; 47(8):974-979. Yamada S, Fujii T, Hirakawa A, Takami H, Suenaga M, Hayashi M, Niwa Y, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 30028445.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    120. Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0). Cancer Sci. 2018 Sep; 109(9):2980-2985. Sunami K, Takahashi H, Tsuchihara K, Takeda M, Suzuki T, Naito Y, Sakai K, Dosaka-Akita H, Ishioka C, Kodera Y, Muto M, Wakai T, Yamazaki K, Yasui W, Bando H, Fujimoto Y, Fukuoka S, Harano K, Kawazoe A, Kimura G, Koganemaru S, Kogawa T, Kotani D, Kuboki Y, Matsumoto H, Matsumoto S, Mishima S, Nakamura Y, Sawada K, Shingaki S, Shitara K, Umemoto K, Umemura S, Yasuda K, Yoshino T, Yamamoto N, Nishio K. PMID: 30187675.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    121. Clinical Impact of Neoadjuvant Therapy on Nutritional Status in Pancreatic Cancer. Ann Surg Oncol. 2018 Oct; 25(11):3365-3371. Tashiro M, Yamada S, Sonohara F, Takami H, Suenaga M, Hayashi M, Niwa Y, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. PMID: 30097739.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    122. Impact of the Controlling Nutritional Status Score on the Prognosis After Curative Resection of Pancreatic Ductal Adenocarcinoma. Pancreas. 2018 08; 47(7):823-829. Kato Y, Yamada S, Suenaga M, Takami H, Niwa Y, Hayashi M, Iwata N, Kanda M, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 29975352.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    123. Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study). Oncologist. 2018 08; 23(8):919-927. Nakayama G, Mitsuma A, Sunagawa Y, Ishigure K, Yokoyama H, Matsui T, Nakayama H, Nakata K, Ishiyama A, Asada T, Umeda S, Ezaka K, Hattori N, Takami H, Kobayashi D, Tanaka C, Kanda M, Yamada S, Koike M, Fujiwara M, Fujii T, Murotani K, Ando Y, Kodera Y. PMID: 30049885.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    124. Splenic vein resection together with the pancreatic parenchyma versus separated resection after isolation of the parenchyma during distal pancreatectomy (COSMOS-DP trial): study protocol for a randomised controlled trial. Trials. 2018 Jul 11; 19(1):369. Yamada S, Fujii T, Kawai M, Shimokawa T, Nakamura M, Murakami Y, Satoi S, Eguchi H, Nagakawa Y, Kodera Y, Yamaue H. PMID: 29996884.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    125. Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion? Ann Gastroenterol Surg. 2018 Sep; 2(5):339-347. Kodera Y. PMID: 30238074.
      View in: PubMed   Mentions:
    126. Gain in polycrystalline Nd-doped alumina: leveraging length scales to create a new class of high-energy, short pulse, tunable laser materials. Light Sci Appl. 2018; 7:33. Penilla EH, Devia-Cruz LF, Duarte MA, Hardin CL, Kodera Y, Garay JE. PMID: 30839607.
      View in: PubMed   Mentions:
    127. Overexpression of FGFR1 Promotes Peritoneal Dissemination Via Epithelial-to-Mesenchymal Transition in Gastric Cancer. Cancer Genomics Proteomics. 2018 Jul-Aug; 15(4):313-320. Shimizu D, Saito T, Ito S, Masuda T, Kurashige J, Kuroda Y, Eguchi H, Kodera Y, Mimori K. PMID: 29976636.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    128. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma. Clin Nucl Med. 2018 Jul; 43(7):482-485. Nakanishi K, Kikumori T, Miyajima N, Takano Y, Noda S, Takeuchi D, Iwano S, Kodera Y. PMID: 29688947.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    129. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer. Sci Rep. 2018 06 29; 8(1):9846. Tanaka N, Yamada S, Sonohara F, Suenaga M, Hayashi M, Takami H, Niwa Y, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. PMID: 29959362.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    130. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer. Expert Rev Gastroenterol Hepatol. 2018 Jul; 12(7):657-670. Sawaki K, Kanda M, Kodera Y. PMID: 29902383.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    131. Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer. World J Gastrointest Oncol. 2018 Jun 15; 10(6):124-136. Shimizu D, Kanda M, Kodera Y. PMID: 29988904.
      View in: PubMed   Mentions:
    132. SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells. Oncogene. 2018 09; 37(39):5355-5366. Kanda M, Tanaka H, Shimizu D, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hattori N, Suenaga M, Hayashi M, Iwata N, Yamada S, Fujiwara M, Kodera Y. PMID: 29858600.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    133. A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer. BMC Cancer. 2018 May 25; 18(1):596. Hirooka Y, Kasuya H, Ishikawa T, Kawashima H, Ohno E, Villalobos IB, Naoe Y, Ichinose T, Koyama N, Tanaka M, Kodera Y, Goto H. PMID: 29801474.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    134. Pattern-Specific Transcriptomics Identifies ASGR2 as a Predictor of Hematogenous Recurrence of Gastric Cancer. Mol Cancer Res. 2018 09; 16(9):1420-1429. Tanaka H, Kanda M, Miwa T, Tanaka C, Kobayashi D, Umeda S, Shibata M, Suenaga M, Hattori N, Hayashi M, Iwata N, Yamada S, Nakayama G, Fujiwara M, Kodera Y. PMID: 29784667.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    135. Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial. J Clin Oncol. 2018 07 01; 36(19):1922-1929. Ishigami H, Fujiwara Y, Fukushima R, Nashimoto A, Yabusaki H, Imano M, Imamoto H, Kodera Y, Uenosono Y, Amagai K, Kadowaki S, Miwa H, Yamaguchi H, Yamaguchi T, Miyaji T, Kitayama J. PMID: 29746229.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    136. A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer. Cancer Med. 2018 06; 7(6):2463-2471. Kanda M, Murotani K, Tanaka H, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Hattori N, Suenaga M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. PMID: 29733517.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    137. Optical trocar access for initial trocar placement in laparoscopic gastrointestinal surgery: A propensity score-matching analysis. Asian J Endosc Surg. 2019 Jan; 12(1):37-42. Tanaka C, Fujiwara M, Kanda M, Murotani K, Iwata N, Hayashi M, Kobayashi D, Yamada S, Kodera Y. PMID: 29673123.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    138. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer. Ann Surg Oncol. 2018 Jul; 25(7):2083-2090. Sawaki K, Kanda M, Miwa T, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. PMID: 29663169.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    139. Integrated multigene expression panel to prognosticate patients with gastric cancer. Oncotarget. 2018 Apr 10; 9(27):18775-18785. Kanda M, Murotani K, Tanaka H, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Hattori N, Suenaga M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. PMID: 29721160.
      View in: PubMed   Mentions: 2     Fields:    
    140. Significance of Lysyl oxidase-like 2 gene expression on the epithelial-mesenchymal status of hepatocellular carcinoma. Oncol Rep. 2018 Jun; 39(6):2664-2672. Ninomiya G, Yamada S, Hayashi M, Takeda S, Suenaga M, Takami H, Kanda M, Iwata N, Niwa Y, Tanaka C, Kobayashi D, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. PMID: 29620290.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    141. A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial. Gastric Cancer. 2018 11; 21(6):1014-1023. Takahashi N, Kanda M, Yoshikawa T, Takiguchi N, Fujitani K, Miyamoto K, Ito Y, Takayama O, Imano M, Mitsumori N, Sakamoto J, Morita S, Kodera Y. PMID: 29536296.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    142. Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer. Cancer Chemother Pharmacol. 2018 05; 81(5):815-821. Yamada S, Fujii T, Yokoyama Y, Kawashima H, Maeda O, Suzuki K, Okada T, Ono E, Yamaguchi J, Takano N, Takami H, Hayashi M, Niwa Y, Hirooka Y, Ito Y, Naganawa S, Ando Y, Nagino M, Goto H, Kodera Y. PMID: 29502139.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    143. Preoperative Albumin-Bilirubin Grade Predicts Recurrences After Radical Gastrectomy in Patients with pT2-4 Gastric Cancer. World J Surg. 2018 03; 42(3):773-781. Kanda M, Tanaka C, Kobayashi D, Uda H, Inaoka K, Tanaka Y, Hayashi M, Iwata N, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. PMID: 28920160.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    144. A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial. Gastric Cancer. 2018 09; 21(5):811-818. Nishikawa K, Tsuburaya A, Yoshikawa T, Takahashi M, Tanabe K, Yamaguchi K, Yoshino S, Namikawa T, Aoyama T, Rino Y, Kawada J, Tsuji A, Taira K, Kimura Y, Kodera Y, Hirashima Y, Yabusaki H, Hirabayashi N, Fujitani K, Miyashita Y, Morita S, Sakamoto J. PMID: 29488122.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    145. Postoperative adalimumab maintenance therapy for Japanese patients with Crohn's disease: a single-center, single-arm phase II trial (CCOG-1107 study). Surg Today. 2018 Jun; 48(6):609-617. Asada T, Nakayama G, Tanaka C, Kobayashi D, Ezaka K, Hattori N, Kanda M, Yamada S, Koike M, Kodera Y. PMID: 29476258.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    146. Introducing laparoscopic total gastrectomy for gastric cancer in general practice: a retrospective cohort study based on a nationwide registry database in Japan. Gastric Cancer. 2019 01; 22(1):202-213. Kodera Y, Yoshida K, Kumamaru H, Kakeji Y, Hiki N, Etoh T, Honda M, Miyata H, Yamashita Y, Seto Y, Kitano S, Konno H. PMID: 29427039.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    147. Obesity does not affect peri- and postoperative outcomes of transabdominal laparoscopic adrenalectomy. Nagoya J Med Sci. 2018 02; 80(1):21-28. Inaishi T, Kikumori T, Takeuchi D, Ishihara H, Miyajima N, Shibata M, Takano Y, Nakanishi K, Noda S, Kodera Y. PMID: 29581611.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    148. Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report. Surg Case Rep. 2017 Dec 28; 3(1):131. Shibata M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Aita Y, Takekoshi K, Kodera Y, Kikumori T. PMID: 29282558.
      View in: PubMed   Mentions:
    149. Surgical outcomes of laparoscopic distal gastrectomy compared to open distal gastrectomy: A retrospective cohort study based on a nationwide registry database in Japan. Ann Gastroenterol Surg. 2018 Jan; 2(1):55-64. Yoshida K, Honda M, Kumamaru H, Kodera Y, Kakeji Y, Hiki N, Etoh T, Miyata H, Yamashita Y, Seto Y, Kitano S, Konno H. PMID: 29863131.
      View in: PubMed   Mentions:
    150. Gastric venous congestion and bleeding in association with total pancreatectomy. J Hepatobiliary Pancreat Sci. 2018 Feb; 25(2):150-154. Nakao A, Yamada S, Fujii T, Tanaka H, Oshima K, Oshima Y, Iede K, Kobayashi H, Kimura Y, Kodera Y. PMID: 29143477.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    151. Morbidity and mortality from a propensity score-matched, prospective cohort study of laparoscopic versus open total gastrectomy for gastric cancer: data from a nationwide web-based database. Surg Endosc. 2018 06; 32(6):2766-2773. Etoh T, Honda M, Kumamaru H, Miyata H, Yoshida K, Kodera Y, Kakeji Y, Inomata M, Konno H, Seto Y, Kitano S, Hiki N. PMID: 29218676.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    152. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma. Epigenetics. 2017; 12(10):865-874. Kurimoto K, Hayashi M, Guerrero-Preston R, Koike M, Kanda M, Hirabayashi S, Tanabe H, Takano N, Iwata N, Niwa Y, Takami H, Kobayashi D, Tanaka C, Yamada S, Nakayama G, Sugimoto H, Fujii T, Fujiwara M, Kodera Y. PMID: 29099287.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    153. Prognostic Value of Long Non-Coding RNA HULC and MALAT1 Following the Curative Resection of Hepatocellular Carcinoma. Sci Rep. 2017 11 23; 7(1):16142. Sonohara F, Inokawa Y, Hayashi M, Yamada S, Sugimoto H, Fujii T, Kodera Y, Nomoto S. PMID: 29170515.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    154. Usefulness of endoscopic ultrasonography-elastography as a predictive tool for the occurrence of pancreatic fistula after pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. 2017 Dec; 24(12):649-656. Kuwahara T, Hirooka Y, Kawashima H, Ohno E, Yokoyama Y, Fujii T, Nakamura S, Kodera Y, Nagino M, Goto H. PMID: 29032609.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    155. Effect of Plasma-Activated Lactated Ringer's Solution on Pancreatic Cancer Cells In Vitro and In Vivo. Ann Surg Oncol. 2018 Jan; 25(1):299-307. Sato Y, Yamada S, Takeda S, Hattori N, Nakamura K, Tanaka H, Mizuno M, Hori M, Kodera Y. PMID: 29139022.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    156. Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models. Breast Cancer Res Treat. 2018 01; 167(2):439-450. Adachi Y, Yoshimura M, Nishida K, Usuki H, Shibata K, Hattori M, Kondo N, Yatabe Y, Iwata H, Kikumori T, Kodera Y, Nakanishi H. PMID: 29027049.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    157. Emerging evidence of molecular biomarkers in hepatocellular carcinoma. Histol Histopathol. 2018 Apr; 33(4):343-355. Umeda S, Kanda M, Kodera Y. PMID: 28959824.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    158. Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort study. Gastric Cancer. 2018 Jan; 21(1):162-170. Hiki N, Honda M, Etoh T, Yoshida K, Kodera Y, Kakeji Y, Kumamaru H, Miyata H, Yamashita Y, Inomata M, Konno H, Seto Y, Kitano S. PMID: 28887712.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    159. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma. BMC Cancer. 2017 Sep 01; 17(1):610. Umeda S, Kanda M, Sugimoto H, Tanaka H, Hayashi M, Yamada S, Fujii T, Takami H, Niwa Y, Iwata N, Tanaka C, Kobayashi D, Fujiwara M, Kodera Y. PMID: 28863781.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    160. An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma. Oncotarget. 2017 Sep 19; 8(41):71070-71079. Kanda M, Murotani K, Sugimoto H, Miwa T, Umeda S, Suenaga M, Hayashi M, Hattori N, Tanaka C, Kobayashi D, Yamada S, Fujiwara M, Kodera Y. PMID: 29050343.
      View in: PubMed   Mentions: 1     Fields:    
    161. Identification of NCCRP1 as an epigenetically regulated tumor suppressor and biomarker for malignant phenotypes of squamous cell carcinoma of the esophagus. Oncol Lett. 2017 Oct; 14(4):4822-4828. Miwa T, Kanda M, Koike M, Iwata N, Tanaka H, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Fujii T, Fujiwara M, Kodera Y. PMID: 29085486.
      View in: PubMed   Mentions:
    162. Clinical effectiveness of geriatric assessment for predicting the tolerability of outpatient chemotherapy in older adults with cancer. J Geriatr Oncol. 2018 01; 9(1):84-86. Hayashi N, Matsuoka A, Goto H, Gotoh M, Kiyoi H, Kodera Y, Nagino M, Nagashima F, Ando Y. PMID: 28802840.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    163. Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials. Front Oncol. 2017; 7:149. Eissa IR, Naoe Y, Bustos-Villalobos I, Ichinose T, Tanaka M, Zhiwen W, Mukoyama N, Morimoto T, Miyajima N, Hitoki H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. PMID: 28770166.
      View in: PubMed   Mentions:
    164. Overexpression of Derlin 3 is associated with malignant phenotype of breast cancer cells. Oncol Rep. 2017 Sep; 38(3):1760-1766. Shibata M, Kanda M, Tanaka H, Umeda S, Miwa T, Shimizu D, Hayashi M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Kodera Y, Kikumori T. PMID: 28713959.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    165. Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society. Surgery. 2017 10; 162(4):784-791. Yamada S, Fujii T, Takami H, Hayashi M, Iwata N, Kanda M, Tanaka C, Sugimoto H, Nakayama G, Koike M, Fujiwara M, Kodera Y. PMID: 28655416.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    166. FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells. Ann Surg Oncol. 2017 Nov; 24(12):3771-3779. Miwa T, Kanda M, Tanaka H, Tanaka C, Kobayashi D, Umeda S, Iwata N, Hayashi M, Yamada S, Fujii T, Fujiwara M, Kodera Y. PMID: 28560594.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    167. Review of recent molecular landscape knowledge of gastric cancer. Histol Histopathol. 2018 Jan; 33(1):11-26. Shimizu D, Kanda M, Kodera Y. PMID: 28447336.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    168. Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy. Dig Surg. 2018; 35(1):55-63. Uda H, Kanda M, Tanaka C, Kobayashi D, Inaoka K, Tanaka Y, Hayashi M, Iwata N, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. PMID: 28441659.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    169. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer. World J Gastroenterol. 2017 Apr 14; 23(14):2519-2526. Inaoka K, Kanda M, Uda H, Tanaka Y, Tanaka C, Kobayashi D, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. PMID: 28465636.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    170. Expression of regulatory factor X1 can predict the prognosis of breast cancer. Oncol Lett. 2017 Jun; 13(6):4334-4340. Shibata M, Kanda M, Shimizu D, Tanaka H, Umeda S, Hayashi M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Kodera Y, Kikumori T. PMID: 28599435.
      View in: PubMed   Mentions:
    171. The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902). BMC Cancer. 2017 04 04; 17(1):243. Nakayama G, Ishigure K, Yokoyama H, Uehara K, Kojima H, Ishiyama A, Hayashi N, Takano N, Hattori N, Kobayashi D, Tanaka C, Hayashi M, Kanda M, Yamada S, Sugimoto H, Koike M, Fujiwara M, Fujii T, Murotani K, Ando Y, Kodera Y. PMID: 28376737.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    172. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma. Int J Oncol. 2017 May; 50(5):1647-1654. Asano T, Yamada S, Fuchs BC, Takami H, Hayashi M, Sugimoto H, Fujii T, Tanabe KK, Kodera Y. PMID: 28350091.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    173. Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer. Oncol Lett. 2017 May; 13(5):3363-3368. Sonohara F, Inokawa Y, Hayashi M, Kodera Y, Nomoto S. PMID: 28529571.
      View in: PubMed   Mentions:
    174. Quality of life after total vs distal gastrectomy with Roux-en-Y reconstruction: Use of the Postgastrectomy Syndrome Assessment Scale-45. World J Gastroenterol. 2017 Mar 21; 23(11):2068-2076. Takahashi M, Terashima M, Kawahira H, Nagai E, Uenosono Y, Kinami S, Nagata Y, Yoshida M, Aoyagi K, Kodera Y, Nakada K. PMID: 28373774.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    175. Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity. Oncolytic Virother. 2017; 6:31-38. Hotta Y, Kasuya H, Bustos I, Naoe Y, Ichinose T, Tanaka M, Kodera Y. PMID: 28331843.
      View in: PubMed   Mentions:
    176. Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan. Surg Today. 2017 Aug; 47(8):899-907. Kodera Y. PMID: 28247105.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    177. Nutritional Recovery after Open and Laparoscopic Distal Gastrectomy for Early Gastric Cancer: A Prospective Multicenter Comparative Trial (CCOG1204). Dig Surg. 2018; 35(1):11-18. Matsushita H, Tanaka C, Murotani K, Misawa K, Ito S, Ito Y, Kanda M, Mochizuki Y, Ishigure K, Yaguchi T, Teramoto J, Nakayama H, Kawase Y, Fujiwara M, Kodera Y. PMID: 28226330.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    178. Gastric cancer treated by endoscopic submucosal dissection or endoscopic mucosal resection in Japan from 2004 through 2006: JGCA nationwide registry conducted in 2013. Gastric Cancer. 2017 Sep; 20(5):834-842. Tanabe S, Hirabayashi S, Oda I, Ono H, Nashimoto A, Isobe Y, Miyashiro I, Tsujitani S, Seto Y, Fukagawa T, Nunobe S, Furukawa H, Kodera Y, Kaminishi M, Katai H. PMID: 28205058.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    179. Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study. World J Gastroenterol. 2017 Feb 14; 23(6):1090-1097. Maeda O, Matsuoka A, Miyahara R, Funasaka K, Hirooka Y, Fukaya M, Nagino M, Kodera Y, Goto H, Ando Y. PMID: 28246483.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    180. Stapling an extracorporeal Billroth-I anastomosis by the complete double stapling technique after laparoscopy-assisted distal gastrectomy. Asian J Endosc Surg. 2017 May; 10(2):137-142. Tanaka C, Fujiwara M, Kanda M, Murotani K, Iwata N, Hayashi M, Kobayashi D, Yamada S, Nakayama G, Sugimoto H, Koike M, Fujii T, Kodera Y. PMID: 28127939.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    181. [HOSPITAL EXCHANGE PROGRAM FOR YOUNG SURGEONS]. Nihon Geka Gakkai Zasshi. 2017 Jan; 118(1):2-3. Iwase H, Kodera Y. PMID: 30173486.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    182. Unprecedented Electro-Optic Performance in Lead-Free Transparent Ceramics. Adv Mater. 2016 Sep; 28(36):7970-7977. Dupuy AD, Kodera Y, Garay JE. PMID: 27383583.
      View in: PubMed   Mentions:    Fields:    
    183. Predictive value of drain amylase content for peripancreatic inflammatory fluid collections after laparoscopic (assisted) distal gastrectomy. Surg Endosc. 2016 10; 30(10):4353-62. Kanda M, Fujiwara M, Tanaka C, Kobayashi D, Iwata N, Mizuno A, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Kodera Y. PMID: 26857580.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    Yasuhiro's Networks
    Concepts (348)
    Derived automatically from this person's publications.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _